Continuous manufacturing of extended release tablets via powder mixing and direct compression.

The aim of the current work was to explore continuous dry powder mixing and direct compression for manufacturing of extended release (ER) matrix tablets. The study was span out with a challenging formulation design comprising ibuprofen compositions with varying particle size and a relatively low amount of the matrix former hydroxypropyl methylcellulose (HPMC). Standard grade HPMC (CR) was compared to a recently developed direct compressible grade (DC2). The work demonstrate that ER tablets with desired quality attributes could be manufactured via integrated continuous mixing and direct compression. The most robust tablet quality (weight, assay, tensile strength) was obtained using high mixer speed and large particle size ibuprofen and HPMC DC2 due to good powder flow. At low mixer speed it was more difficult to achieve high quality low dose tablets. Notably, with HPMC DC2 the processing conditions had a significant effect on drug release. Longer processing time and/or faster mixer speed was needed to achieve robust release with compositions containing DC2 compared with those containing CR. This work confirms the importance of balancing process parameters and material properties to find consistent product quality. Also, adaptive control is proven a pivotal means for control of continuous manufacturing systems.

[1]  Gabriele Betz,et al.  Use of near-infrared spectroscopy to quantify drug content on a continuous blending process: influence of mass flow and rotation speed variations. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[2]  P. Poechlauer,et al.  Continuous Processing in the Manufacture of Active Pharmaceutical Ingredients and Finished Dosage Forms: An Industry Perspective , 2012 .

[3]  Fernando J. Muzzio,et al.  Characterizing continuous powder mixing using residence time distribution , 2011 .

[4]  Fernando J. Muzzio,et al.  Effects of powder flow properties and shear environment on the performance of continuous mixing of pharmaceutical powders , 2013 .

[5]  A. Larsson,et al.  The Impact of Dose and Solubility of Additives on the Release from HPMC Matrix Tablets—Identifying Critical Conditions , 2009, Pharmaceutical Research.

[6]  H Leuenberger,et al.  New trends in the production of pharmaceutical granules: the classical batch concept and the problem of scale-up. , 2001, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[7]  Aditya U. Vanarase,et al.  Effect of operating conditions and design parameters in a continuous powder mixer , 2011 .

[8]  James M. B. Evans,et al.  End-to-end continuous manufacturing of pharmaceuticals: integrated synthesis, purification, and final dosage formation. , 2013, Angewandte Chemie.

[9]  I. Caraballo.  Factors affecting drug release from hydroxypropyl methylcellulose matrix systems in the light of classical and percolation theories , 2010, Expert opinion on drug delivery.

[10]  Fernando J. Muzzio,et al.  Characterization of continuous convective powder mixing processes , 2008 .

[11]  Lakshman Pernenkil,et al.  A review on the continuous blending of powders , 2006 .

[12]  Henri Berthiaux,et al.  Continuous mixing of powder mixtures with pharmaceutical process constraints , 2008 .

[13]  John Bridgwater,et al.  Mixing of powders and granular materials by mechanical means—A perspective , 2012 .

[14]  J. R. Howard,et al.  Influence of some process variables on product properties for a hydrophilic matrix controlled release tablet , 1992 .

[15]  Charles Cooney,et al.  Regulatory and Quality Considerations for Continuous Manufacturing May 20-21, 2014 Continuous Manufacturing Symposium. , 2015, Journal of pharmaceutical sciences.

[16]  San Kiang,et al.  Can pharmaceutical process development become high tech , 2006 .

[17]  W. Price.  Making Do in Making Drugs: Innovation Policy and Pharmaceutical Manufacturing , 2013 .

[19]  B. Gururajan,et al.  Roller Compaction of Hydrophilic Extended Release Tablets—Combined Effects of Processing Variables and Drug/Matrix Former Particle Size , 2015, AAPS PharmSciTech.

[20]  Marianthi G. Ierapetritou,et al.  Effects of rotation rate, mixing angle, and cohesion in two continuous powder mixers—A statistical approach , 2009 .

[21]  Fernando J. Muzzio,et al.  Method for characterization of loss-in-weight feeder equipment , 2012 .

[22]  H Leuenberger,et al.  New trends in the production of pharmaceutical granules: batch versus continuous processing. , 2001, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[23]  Changquan Calvin Sun.  Setting the bar for powder flow properties in successful high speed tableting , 2010 .

[24]  A. Larsson,et al.  Simultaneous probing of swelling, erosion and dissolution by NMR-microimaging--effect of solubility of additives on HPMC matrix tablets. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[25]  Vadim Mizonov,et al.  FLOW ANALYSIS AND MARKOV CHAIN MODELLING TO QUANTIFY THE AGITATION EFFECT IN A CONTINUOUS POWDER MIXER , 2006 .

[26]  Aibing Yu,et al.  DEM study of the flow of cohesive particles in a screw feeder , 2014 .

[27]  Aditya U. Vanarase,et al.  Investigation of the effect of impeller rotation rate, powder flow rate, and cohesion on powder flow behavior in a continuous blender using PEPT , 2010 .

[28]  Sigurd Buchholz,et al.  Future manufacturing approaches in the chemical and pharmaceutical industry , 2010 .

[29]  Jean Paul Remon,et al.  Continuous granulation in the pharmaceutical industry , 2005 .

[30]  Lawrence X. Yu,et al.  Modernizing Pharmaceutical Manufacturing: from Batch to Continuous Production , 2015, Journal of Pharmaceutical Innovation.

[31]  Henri Berthiaux,et al.  Experimental study of the stirring conditions taking place in a pilot plant continuous mixer of particulate solids , 2005 .

[32]  Matthew Roberts,et al.  Production of extended release mini-tablets using directly compressible grades of HPMC , 2013, Drug development and industrial pharmacy.

[33]  Marianthi G. Ierapetritou,et al.  An integrated approach for dynamic flowsheet modeling and sensitivity analysis of a continuous tablet manufacturing process , 2012, Comput. Chem. Eng..

[34]  M. Levina,et al.  The effect of HPMC particle size on the drug release rate and the percolation threshold in extended-release mini-tablets , 2015, Drug Development and Industrial Pharmacy.

[35]  J Yliruusi,et al.  New insights into segregation during tabletting. , 2010, International journal of pharmaceutics.

[36]  A. Rajabi-Siahboomi,et al.  Influence of drug:hydroxypropylmethylcellulose ratio, drug and polymer particle size and compression force on the release of diclofenac sodium from HPMC tablets. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[37]  Dimitrios I. Gerogiorgis,et al.  Economic Analysis of Integrated Continuous and Batch Pharmaceutical Manufacturing: A Case Study , 2011 .

[38]  K. Plumb,et al.  Continuous Processing in the Pharmaceutical Industry: Changing the Mind Set , 2005 .